Occlutech Atrial Flow Regulator

Case Presentations

2018 - Creation of a defined and stable Fontan fenestration with the new Occlutech Atrial Flow Regulator.

Lehner A, Schulze-Neick I, Haas NA.

This report describes the first clinical experience with the new Occlutech Atrial Flow Regulator (AFR®) device for implementation of a late Fontan fenestration. The AFR® device secured a defined diameter of the fenestration without spontaneous re-occlusion of this extra-anatomic perforation. This ensured a permanent clinical improvement of our failing Fontan patient.

2017 - Atrial septostomy with a predefined diameter using a novel occlutech atrial flow regulator improves symptoms and cardiac index in patients with severe pulmonary arterial hypertension.

Rajeshkumar R, Pavithran S, Sivakumar K, Vettukattil JJ.

Atrial septostomy with a predefined diameter using a novel occlutech atrial flow regulator improves symptoms and cardiac index in patients with severe pulmonary arterial hypertension.

AFR Case 1 - News article

Dr. Vettukattil

"‘I think I’m Wonder Woman now’ - Mary Bostwick delights in her new life after becoming a heart-lung transplant recipient."

AFR Case 2 - News article

Dr. Vettukattil

"‘A last resort’ keeps her heart pumpingDebra Peck’s parents were told she wouldn’t live long. Now 60, she is the second person in the world to get an innovative new device."


The products shown may not be available in all markets. Availability for a specific therapeutic purpose, in any specific country or region, is subject to obtaining necessary regulatory clearance.